## Answer
The patient has advanced heart failure and kidney dysfunction, with an eGFR of 30 ml/min per 1.73 m2. The placement of a ventricular assist device (VAD) is being considered to manage her heart failure. The question is about the expected renal outcomes of VAD placement.

Option A suggests that she is likely to experience at least a transient improvement in kidney function. This is plausible because VADs can improve cardiac output, which can in turn improve renal perfusion and function. 

Option B suggests that if her eGFR increases to > 60 ml/min per 1.73 m2, her 1-year survival following transplant is likely to be worse than that in those with normal pre-VAD eGFR. This doesn't seem logical as improved kidney function (higher eGFR) is generally associated with better outcomes.

Option C suggests that her risk of post-VAD acute kidney injury (AKI) is equivalent to that in those with normal pre-VAD kidney function. This is unlikely because patients with pre-existing kidney disease are generally at higher risk of AKI.

Option D suggests that she can expect a sustained increase in eGFR of > 50 ml/min per 1.73 m2 above the pre-VAD eGFR at 1 year while awaiting transplant. This seems overly optimistic, as while VADs can improve renal function, a sustained increase of this magnitude is not typically seen.

Therefore, the answer is [A. She is likely to experience at least a transient improvement in kidney function].